This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A phase IIa study to characterize the effects of C...
Clinical trial

A phase IIa study to characterize the effects of CCL2 inhibition with the Spiegelmer� NOX-E36 in patients with type 2 diabetes mellitus and albuminuria.

Read time: 1 mins
Last updated:6th Dec 2011
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest